Navigation Links
Cardiac Science Announces Third Quarter Results
Date:11/9/2009

holders to eliminate uncertainty and begin to focus on the progress we've made in our turnaround. Operationally, we continue to move at a brisk pace in improving our systems and capabilities with an eye toward building a stronger foundation for future growth," said Dave Marver, president and chief executive officer. "We have several new technologies slated for introduction in the next 12 months. The introduction of our new vital signs monitors in cooperation with Omron is one of many enhancements we'll be making to our product line that leverage our brands, distribution, and large installed customer base."

Third Quarter Financial Results

Third quarter revenue of $38.9 million represented a decrease of 28% compared to the $54.0 million in revenue reported in the third quarter of 2008. Third quarter gross margin was 0.2%, inclusive of the $18.5 million charge relating to the AED field initiative. Excluding this charge, pro forma gross margin would have been 47.8%, a slight decrease from reported third quarter 2008 gross margin, which was 48.4%. The decrease in gross margin on a pro forma basis was due primarily to lower service margins relating to lower revenue being spread over a somewhat fixed cost structure.

Operating expenses in the third quarter of 2009 were $22.8 million, a modest increase from the $22.1 million for the third quarter of 2008. Inclusive of the $18.5 million charge relating to the AED field product update and the $44.0 million charge related to deferred tax assets, the Company reported a net loss of $66.5 million, or $2.85 loss per share in the third quarter of 2009.

EBITDA was negative $21.1 million for the third quarter of 2009. Adjusted EBITDA, which excludes stock-based compensation expense and the costs relating to the AED field initiative, was negative $1.9 million for the third quarter of 2009.

The Company had $31.6 million in cash and cash equivalents as of September 30, 2009,
'/>"/>

SOURCE Cardiac Science Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Personalized Medicine - The Genomic Revolution in Cardiac Care
2. FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function
3. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
4. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
5. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
6. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
7. Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
10. DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects
11. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... /CNW/ - Sante Medical Hair Restoration is now offering ... The ARTAS Robotic System is a ... hair for transplantation. This latest development in minimally-invasive ... no linear scar. "The ARTAS technology ... restoration surgery." says Dr. Louis Grondin , ...
(Date:3/3/2015)... Registration is officially open for MEDTEC China South 2015, which ... Convention & Exhibition Center. The Shenzhen ... MEDTEC China family of events. MEDTEC China South, an exhibition ... the South China market through staging ... for China,s medical device industry. This ...
(Date:3/3/2015)... 3, 2015  RedHill Biopharma Ltd. (NASDAQ/TASE: ... biopharmaceutical company primarily focused on late clinical-stage, ... diseases, including gastrointestinal cancers, today announced that ... Officer, will be presenting at VirtualInvestorConferences.com, a ... March 5, 2015, at 10:00 am EST. ...
Breaking Medicine Technology:No linear scar. Permanent results. 2Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 4
... , , , BOSTON, Dec. 9 Solos ... Company has generated $46,840.43 in sales for the month of ... November 2009 versus $31,508.76 for October 2008 and $32,028.52 for ... Endoscopy, Inc. is a HealthCare instrument company whose mission is ...
... Texas, Dec. 9 /PRNewswire-FirstCall/ -- ULURU ... presentation on Altrazeal(TM) Transforming Powder Dressing will be made at ... to be held December 10-13, 2009 in St Thomas, U.S. ... of Altrazeal(TM) related to the development of future products in ...
Cached Medicine Technology:ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3
(Date:3/4/2015)... Ada Products Company, Inc ., an ... strategic partnership with the Dental Exchange in an effort ... them to engaging, inspiring ideas, products, career opportunities, and ... Dental Exchange is a first-of-its kind online resource ... other social platforms, the Dental Exchange dives much deeper ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... Surgical endoscopy is witnessing strong growth worldwide, supported ... The development of robot-assisted surgery and single incision ... market. Major benefits of minimally invasive surgery, driving ... reduced trauma to the surgical site, lower blood ...
(Date:3/4/2015)... Bird B Gone, the leader in bird ... offers its popular plastic (polycarbonate) bird spike in seven ... bird deterrent is ready-to-use and comes in a ... of the building or structure onto which it is ... light grey, brown, black and tan—make the spikes virtually ...
(Date:3/4/2015)... Texas (PRWEB) March 04, 2015 ... today announced that Alan Daugherty has been named ... immediately. Daugherty has served as interim CEO of ... , “Alan has provided tremendous leadership during his ... abilities leading hospital strategy and developing relationships with ...
(Date:3/3/2015)... Anik Singal's Profit Academy - ... marketers has become the talk of the town ... surrounding the course's general release has garnered the ... her to review the program's content and publish ... biggest keys to success with Internet marketing is ...
Breaking Medicine News(10 mins):Health News:Ada Products Company, Inc. Announces Strategic Partnership with the Dental Exchange 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2
... arteries, veins and capillaries become diseased, patients can experience ... stroke and heart attack.// Dennis Gable, M.D., a vascular ... Center at Plano, provides information about three of the ... ,Varicose veins are large, twisted, swollen blood vessels that ...
... The University of Pennsylvania School of Medicine has isolated a ... to differentiate into several cell types.// If the cells ... are grown in increased magnitude, then it is possible to ... of disorders that includes peripheral nerve disease, Parkinson's disease, and ...
... Dr. Matt Messina, consumer advisor to the American Dental Association, ... a nice 'bling' to a smile but they// could also ... explained that removable dental fixtures like the 'grills' or 'fronts' ... very happening trends among he younger so called 'hip-hop' generations. ...
... has launched National Transplant Week to raise awareness of the ... place and the number of people// awaiting transplants. ... in Britain has joined the Organ Donor Register. In addition ... transplant lists, only 2,200 actually operations took place. ...
... test results of women in north Queensland have been reviewed ... ,According to the Queensland Health Minister Stephen Robertson there was ... area in recent months. ,9,300 cases were reviewed. ... for further testing and two showed non-malignant cancers. ...
... technique of positron emission tomography (PET) have been able to ... chemistry// and the susceptibility of an individual to resort to ... ,The research, in animals, shows a significant correlation ... for the neurotransmitter dopamine – measured before cocaine use begins ...
Cached Medicine News:Health News:Vascular Disease 101: Discovering and Treating Common Diseases of the Veins 2Health News:Varied Applications of Adult Stem Cells to Treat Host of Disorders in Human 2Health News:Dental Grills harmful For Users 2Health News:National Transplant Week to Raise Need for Organ Donation 2Health News:Definite Connection Between Receptor Levels and Cocaine Abuse Reveals PET Imaging 2Health News:Definite Connection Between Receptor Levels and Cocaine Abuse Reveals PET Imaging 3
The Radionics XKnife RT2 system provides a precise and versatile stereotactic radiation therapy solution....
The Primus linear accelerator is a fully digital, technologically advanced radiation therapy treatment delivery system. It can be configured for delivery of routine, 3-D conformal or IMRT treatments....
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come standard with the latest high-precision dose sculpting technology for advanced tumor control....
... cost-effective, proven and reliable system. Varian ... rapid patient treatment, fastest beam-on times ... less than 500 milliseconds, pulse-to-pulse beam ... stability, greatest number of multileaf collimator ...
Medicine Products: